EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Esaxerenone Inhibits Renal Angiogenesis and Endothelial-Mesenchymal Transition via the VEGFA and TGF-β1 Pathways in Aldosterone-Infused Mice

Xiaomeng Gao iD, Jingyue Chang, Yi Chang, Lili Fan, Ziqian Liu, Cuijuan Zhang, Tatsuo Shimosawa iD, Fan Yang, Qingyou Xu iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241411766 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Xiaomeng Gao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Hebei University of Chinese Medicine, Shijiazhuang 050200, China. Hauptthemen laut MEDLINE: Transforming Growth Factor beta1, Kidney Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Health Commission of Hebei Province, Hebei Provincial Postgraduate Innovative Ability Cultivation Funding Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal fibrosis is an inevitable process in the progression of chronic kidney disease (CKD). Angiogenesis plays an important role in this process. Vascular endothelial cells are involved in renal fibrosis by phenotypic transformation and secretion of extracellular matrix. Aldosterone stimulates mineralocorticoid receptor (MR) activation and induces inflammation, which is important for angiogenesis. Clinically, MR blockers (MRBs) have a protective effect on damaged kidneys, which may be associated with inhibition of angiogenesis. In this study, we used aldosterone-infused mice and found that aldosterone induced angiogenesis and that endothelial-mesenchymal transition (EndMT) in neovascular endothelial cells was involved in renal fibrosis. Notably, aldosterone induced inflammation and stimulated macrophages to secrete vascular endothelial growth factor (VEGF) A to regulate angiogenesis by activating MR, whereas EndMT occurred in response to transforming growth factor-β1 (TGF-β1) induction and participated in renal fibrosis. These effects were antagonized by the MRB esaxerenone. These findings suggest that reducing angiogenesis may be an effective strategy for treating renal fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transforming Growth Factor beta1Kidney DiseasesMiceAnimalsAldosteroneVascular Endothelial Growth Factor AEndothelial CellsSignal TransductionKidneyFibrosisInflammationEpithelial-Mesenchymal TransitionPyrrolesSulfones

Stichwörter der Autor:innen

VEGFAaldosteroneangiogenesismineralocorticoid receptor blockerrenal fibrosis

Substanzen

Transforming Growth Factor beta1AldosteroneVascular Endothelial Growth Factor AesaxerenonePyrrolesSulfones

Autor:innen und Institutionen

  • Graduate School, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.
  • Hebei Key Laboratory of Integrative Medicine on Liver-Kidney Patterns, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.
  • Institute of Integrative Medicine, College of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.
  • Department of Clinical Laboratory, School of Medicine, International University of Health and Welfare, Narita 286-8686, Japan.

ORCID-Profile: Xiaomeng Gao, Tatsuo Shimosawa, Qingyou Xu

Förderung

  • National Natural Science Foundation of China
  • Health Commission of Hebei Province
  • Hebei Provincial Postgraduate Innovative Ability Cultivation Funding Project
  • National Natural Science Foundation Project of China
  • Research Fund Projects of Health Commission of Hebei Province
  • Construction Program of New Research and Development Platform and Institution, the Hebei Province Innovation Ability Promotion Plan

Zitieren

APA

Gao, X., Chang, J., Chang, Y., Fan, L., Liu, Z., Zhang, C., Shimosawa, T., Yang, F., & Xu, Q. (2023). Esaxerenone Inhibits Renal Angiogenesis and Endothelial-Mesenchymal Transition via the VEGFA and TGF-β1 Pathways in Aldosterone-Infused Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411766

Vancouver

Gao X, Chang J, Chang Y, Fan L, Liu Z, Zhang C, et al. Esaxerenone Inhibits Renal Angiogenesis and Endothelial-Mesenchymal Transition via the VEGFA and TGF-β1 Pathways in Aldosterone-Infused Mice. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411766

BibTeX
@article{Gao2023,
  author = {Gao, Xiaomeng and Chang, Jingyue and Chang, Yi and Fan, Lili and Liu, Ziqian and Zhang, Cuijuan and Shimosawa, Tatsuo and Yang, Fan and Xu, Qingyou},
  title = {Esaxerenone Inhibits Renal Angiogenesis and Endothelial-Mesenchymal Transition via the VEGFA and TGF-β1 Pathways in Aldosterone-Infused Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241411766}
}
Kostenlos starten →